Red Whale Primary Care Pod

Gonorrhoea: prevention through vaccination. Also, emotionally-based school avoidance.

12 snips
Sep 12, 2025
Explore the latest advancements in gonorrhoea prevention with a newly available vaccine that could cut risk significantly. Learn about rising infection rates and first-line treatment updates, including ceftriaxone as the go-to antibiotic. Transitioning to emotional well-being, discover the critical issue of emotionally-based school avoidance, its impacts on students, and essential support strategies for families and schools. The necessity for a coordinated response in addressing mental health, especially during school transitions, is also highlighted.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Rapid Rise Of Gonorrhoea Cases

  • Gonorrhoea infections in the UK have more than doubled in the past decade with over 85,000 cases in 2023.
  • It is now the second most common STI and disproportionately affects young people and some minority groups.
ADVICE

Use Ceftriaxone 1 g IM First Line

  • First-line treatment for uncomplicated anogenital and pharyngeal gonorrhoea is ceftriaxone 1 g IM as a single dose.
  • If IM administration is unsuitable or allergy exists, seek GUM guidance for alternative regimens to avoid treatment failure.
ADVICE

Refer And Reinforce Safer-Sex Rules

  • Refer suspected or NAT-positive gonorrhoea cases to genitourinary medicine (GUM) for confirmation and management.
  • Reinforce safe-sex advice and advise abstinence until seven days after all partners complete treatment.
Get the Snipd Podcast app to discover more snips from this episode
Get the app